Holen Sie sich die Stockscreener-App
2.365
10.08%
-0.265
Handel nachbörslich:
2.38
0.015
+0.63%
Finanzdaten der Dare Bioscience Inc-Aktie (DARE)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
99.49%
0.0093
|
1.8079 | 1.00 | - | - |
Operating Expenses
|
13.58%
6.0318
|
6.9793 | 9.3964 | 8.9894 | 8.3826 |
| Benefits Costs and Expenses |
100.00%
-
|
32.97 | - | - | - |
| Costs And Expenses |
2.69%
6.0318
|
6.1985 | 9.3964 | - | - |
| Operating Income/Loss |
16.46%
-6.0225
|
-5.1715 | -8.3964 | -8.9894 | -8.3826 |
| Income/Loss From Continuing Operations Before Tax |
100.03%
0.0093
|
-31.16 | 1.00 | -8.7622 | -8.0425 |
| Income/Loss From Continuing Operations After Tax |
33.63%
-6.7554
|
-5.0552 | -8.2991 | -8.7622 | -8.0425 |
|
Net Income/Loss
|
33.57%
-6.7554
|
-5.0576 | -8.2991 | -8.7622 | -8.0425 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
122.29K%
100.51
|
0.0821 | 91.05 | 86.40 | 85.52 |
| Diluted Average Shares |
122.29K%
100.51
|
0.0821 | 91.05 | 86.40 | 85.52 |
| Basic Earnings Per Share |
16.67%
-0.07
|
-0.06 | -0.09 | -0.10 | -0.09 |
| Diluted Earnings Per Share |
16.67%
-0.07
|
-0.06 | -0.09 | -0.10 | -0.09 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.11%
1.70%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):